PMID: 8527686Jul 1, 1995Paper

Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals

Biopharmaceutics & Drug Disposition
T T Kararli


In addition to metabolic differences, the anatomical, physiological, and biochemical differences in the gastrointestinal (G.I.) tract of the human and common laboratory animals can cause significant variation in drug absorption from the oral route. Among the physiological factors, pH, bile, pancreatic juice, and mucus and fluid volume and content can modify dissolution rates, solubility, transit times, and membrane transport of drug molecules. The microbial content of the G.I. tract can significantly affect the reductive metabolism and enterohepatic circulation of drugs and colonic delivery of formulations. The transit time of dosage forms can be significantly different between species due to different dimensions and propulsive activities of the G.I. tract. The lipid/protein composition of the enterocyte membrane along the G.I. tract can alter binding and passive, active, and carrier-mediated transport of drugs. The location and number of Peyer's patches can also be important in the absorption of large molecules and particulate matter. While small animals, rats, mice, guinea pigs, and rabbits, are most suitable for determining the mechanism of drug absorption and bioavailability values from powder or solution formulations, larg...Continue Reading


Jan 1, 1978·Annual Review of Pharmacology and Toxicology·P Goldman
Sep 1, 1992·Journal of Pharmaceutical Sciences·T T Kararli, J Stolzenbach
Nov 13, 1991·Biochimica Et Biophysica Acta·P Proulx
Jun 1, 1990·Chemical & Pharmaceutical Bulletin·I Yamada, K Haga
Feb 1, 1990·Veterinary Immunology and Immunopathology·H HogenEsch, P J Felsburg
Dec 1, 1989·Gut·R Holmes, R W Lobley
Jan 1, 1989·Laboratory Animals·N G Ghoshal, H S Bal
Jan 1, 1987·Advances in Experimental Medicine and Biology·H HogenEschP J Felsburg
Jan 1, 1987·Current Topics in Microbiology and Immunology·J D Reynolds
Sep 25, 1985·Biochimica Et Biophysica Acta·T A Brasitus, P K Dudeja
Nov 1, 1970·Cellular Immunology·W P FaulkH H Fudenberg
Jul 1, 1973·The Journal of Cell Biology·R Rodewald
Jun 21, 1973·Biochimica Et Biophysica Acta·G G Forstner, J R Wherrett
Nov 1, 1971·Journal of Medical Microbiology·G HawksworthM J Hill
Jul 1, 1965·Canadian Journal of Biochemistry·R P Harpur, J S Popkin
Jul 1, 1966·The American Journal of Digestive Diseases·J S Fordtran, T W Locklear
Nov 14, 1981·Lancet·J S Yudkin
Oct 2, 1981·Biochimica Et Biophysica Acta·K Christiansen, J Carlsen
Jul 11, 1984·Biochimica Et Biophysica Acta·T A Brasitus, D Schachter
Nov 18, 1980·Biochimica Et Biophysica Acta·H HauserD E Bowyer
Aug 1, 1993·The British Journal of Surgery·P E Watkins

❮ Previous
Next ❯


Nov 16, 2002·Archives of Pharmacal Research·Hye J Lee
Mar 23, 2010·Cancer Chemotherapy and Pharmacology·Kenneth M RassnickDonald L Trump
Sep 24, 2005·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Juliana G MachadoMichael P Murtaugh
Sep 29, 2006·Pediatric Surgery International·Thambipillai Sri ParanPrem Puri
Oct 29, 2008·Pediatric Surgery International·Thambipillai Sri ParanPrem Puri
Jun 15, 2011·Histochemistry and Cell Biology·Patricia WidmayerNicole Hass
Feb 8, 2007·Diseases of the Colon and Rectum·Henrique Sarubbi FillmannNorma Possa Marroni
Mar 9, 2011·Cell Biology and Toxicology·Kevin J RandallJohn R Foster
Mar 19, 2009·Digestive Diseases and Sciences·Marcela KopácováStanislav Rejchrt
Sep 1, 2005·Pharmaceutical Research·Natalie L TrevaskisWilliam N Charman
Jan 3, 2006·Pharmaceutical Research·Jianjun ChengRobert S Langer
Mar 27, 2007·Pharmaceutical Research·Chong-Hui GuRonald L Smith
Mar 22, 2007·Pharmaceutical Research·Stefan WillmannJennifer B Dressman
Sep 7, 2007·Pharmaceutical Research·Jae Han Park, Joseph R Robinson
Jun 20, 2007·Pharmaceutical Research·B SarmentoD Ferreira
Sep 12, 2008·Pharmaceutical Research·Takanori HironakaToshikiro Kimura
Oct 16, 2010·Pharmaceutical Research·Luciana A CoráJosé Ricardo Aruda Miranda
Nov 28, 2012·Pharmaceutical Research·Claudia Suenderhauf, Neil Parrott
Mar 3, 2011·International Journal of Clinical Pharmacy·Jonathan L Kaye
Mar 22, 2012·Applied Biochemistry and Biotechnology·Jai V JaiswalSunil W Hajare
Dec 6, 2011·Archives of Pharmacal Research·Caihong XuGang Cheng
Nov 7, 2003·International Journal of Pharmaceutics·Ehab HamedAdel Sakr
Apr 9, 2005·International Journal of Pharmaceutics·Teruko ImaiMasaki Otagiri
Apr 20, 2013·International Journal of Pharmaceutics·René HolmHuiling Mu
Jun 26, 2013·International Journal of Pharmaceutics·Waleed FaisalBrendan T Griffin
Dec 20, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·V SnoeckB M Goddeeris
Jun 5, 1998·Veterinary Immunology and Immunopathology·A J GermanM J Day
Sep 11, 2003·Journal of Neuroimmunology·Benedict T GreenDavid R Brown
Mar 29, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·Y I JeongK Takada
Jun 18, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eytan A KlausnerAmnon Hoffman
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·E Lipka, G L Amidon
Aug 8, 2001·Advanced Drug Delivery Reviews·G A EdwardsW N Charman
Sep 29, 2001·Advanced Drug Delivery Reviews·M ThanouH E Junginger
Oct 19, 2000·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J M DeSessoR D Mavis
Mar 30, 2001·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J M DeSesso, C F Jacobson
Sep 23, 2000·International Journal of Pharmaceutics·J Van GelderP Augustijns

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.